Does The MRD Deliver Value? Yes? No? It Depends! / RBDR

Do you regularly watch RBDR, whether once or up to four times a week? Do you find it informative and entertaining? Help maintain and continue our video based on what you can afford (e.g., $5 or $10 for an individual, perhaps $25 to $50 from a business per month). Visit Patreon.com/RBDR.

—————————————————-

March 14, 2022

Today on RBDR: Swiss research consultant Denyse Drummond-Dunn asks and answers her deliberately controversial question about the benefits of market research departments in the current business environment–and how to deal with underperformance.

No need to spend time searching for today’s RBDR video. Subscribe to receive a FREE, personal email as soon as the latest RBDR is uploaded. Click here: http://ow.ly/CfFWE

Pinterest buys an analyzing firm; Denyse Drummond-Dunn challenges MR industry (RBDR–1/08/2014)

Today: 1) Pinterest founders have watched as startups that could analyze Pinterest content were sold up to other companies in the past 18 months. This week, Pinterest acquired one for itself, VisualGraph. 2) C3Centricity founder Denyse Drummond-Dunn vocalizes the multi-level challenge she blogged to the MR supplier and client community.

Sponsored by uSamp (http://www.usamp.com), the Answer Network offering technology solutions and survey respondents for consumer and business insights.

Research Business DAILY Report is produced by RFL Communications (rflonline.com), publisher of 4 market research newsletters with content that strongly complements RBDR:
• Research Business Report (technological and methodological changes that economically and constructively impact MR)
• Research Conference Report (summarizing conference speeches from around the world that present ideas, philosophies, methods, tactics, etc. that break new ground)
• Research Department Report (profiling the inner workings of MR departments at leading companies around the world)
• Pharma Market Research Report (the world’s Only Publication that exclusively covers the interests, challenges, opportunities, etc. of MR professionals inside pharmaceutical, health care, biotech and medical device companies)